The role of imaging parameters in the diagnosis of developmental dysplasia of the hip based on artificial intelligence: A perspective.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 20. Orthop Rev (Pavia). 2026 Jul 24;18:163927. doi: 10.52965/001c.163927. eCollection 2026. The Association Between Charcot-Marie-Tooth Disease and Developmental Dysplasia of the Hip: A Narrative Review. Alnowaishiri KA(1), AlMutairi LO(2), AlQarni RA(3), Alshaikhi RO(4), Asiri AY(5), Ganbou ZT(6), Alghamdi AA(6), Alamoud AAA(5), AlQahtani MS(7), AlQarni A(8). Author information: (1)Kuwait Institute for Medical Specialization. (2)King Saud bin Abdulaziz University for Health Sciences. (3)Imam Mohammad Ibn Saud Islamic University (IMSIU). (4)King Saudi bin Abdulaziz University for Health Sciences. (5)King Khalid University. (6)King Abdulaziz University. (7)King Khaled University. (8)Security Forces Hospital. Charcot-Marie-Tooth (CMT) disease, a condition comprising a variety of inherited peripheral neuropathies, is marked by progressive degeneration of motor and sensory nerves. The current review examines the link between CMT and developmental dysplasia of the hip (DDH), characterized by abnormal hip joint development. Although the frequency of DDH among CMT patients has been under-investigated, the musculoskeletal complications of CMT (including weakness and abnormal gait) may predispose individuals to hip dysplasia. This narrative review compiles data from 11 publications selected from a systematic search of PubMed and Web of Science. The criteria included established diagnosis of CMT and DDH in patients aged less than 14 years, English language, and availability of full text. This review examined patient characteristics, genetics, diagnosis, and treatment. Research demonstrates a high incidence of hip dysplasia among CMT patients, with some studies reporting 22% in clinical series. Patterns of diagnosis differ among subtypes, with earlier onset of Type-1 CMT. This link is influenced by genetic factors, such as duplication of the PMP22 gene, and family studies show vertical transmission. Diagnosis includes physical examination, X-rays and genetic analysis. Early intervention, including non-surgical and surgical treatment in severe cases, is crucial to management. The link between CMT and DDH highlights the importance of awareness and screening in at-risk groups. Appropriate screening and management algorithms can enhance quality of life. Additional epidemiological and genetic studies are needed to improve diagnostic and treatment strategies. DOI: 10.52965/001c.163927 PMCID: PMC13401817